News

Paradromics Inc. completed its first human procedure with the Connexus BCI, marking a milestone in brain-computer interface ...
Elon Musk's Neuralink is testing its Blindsight brain implant in monkeys, aiming to potentially provide humans with ...
Paradromics implanted its first brain implant device, Connexus, in a human patient last month, successfully recording ...
Paradromics, a competitor of Neuralink, announced Monday it safely implanted a brain-computer interface into a human patient ...
Hospitals are testing brain-computer interface technology, which shows promise in helping motor-impaired patients communicate ...
Elon Musk's Neuralink has filed to raise up to $649 million in a new equity offering, according to an SEC filing submitted ...
Elon Musk's brain-computer interface startup Neuralink secured $650 million in series E funding to expand patient access to ...
Elon Musk’s brain-computer interface company, Neuralink, has secured $650 million in a fresh funding round as it moves ahead with ...
Neuralink competitor Paradromics plans to conduct the first clinical trial of its Connexus brain implant later this year.
Neuralink raised $650M in Series E funding to advance brain-computer tech, with global trials and new use cases now underway.
Elon Musk's brain-computer interface company Neuralink has raised $600 million in new funding at a $9 billion valuation, according to Semafor. The fundraising round follows the company's first human ...
The procedure took place at the University of Michigan with a patient who was already undergoing neurosurgery to treat ...